Previous close | 139.59 |
Open | 138.60 |
Bid | 137.78 x 1000 |
Ask | 137.84 x 800 |
Day's range | 137.58 - 139.59 |
52-week range | 96.80 - 151.58 |
Volume | |
Avg. volume | 1,583,904 |
Market cap | 40.351B |
Beta (5Y monthly) | 1.12 |
PE ratio (TTM) | 33.02 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 0.94 (0.68%) |
Ex-dividend date | 01 Apr 2024 |
1y target est | N/A |
SANTA CLARA, Calif., April 29, 2024--Agilent Technologies, Inc. (NYSE: A) today announced Simon May has been named president of the company’s Diagnostics and Genomics Group (DGG). May, previously executive vice president and president of the Life Science Group at Bio-Rad Laboratories, will join Agilent on May 6.
SANTA CLARA, Calif., April 16, 2024--Agilent Technologies Inc. (NYSE: A) announces that it is the recipient of two 2023 Sustainability Scientists’ Choice awards — Sustainable Supplier of the Year and Sustainable Product of the Year. These awards recognize Agilent as a leader in the area of sustainability.
SANTA CLARA, Calif., April 15, 2024--Agilent Technologies Inc. (NYSE: A) today announced that its GenetiSure Dx Postnatal Assay has received European IVDR Class C Certification. This certification demonstrates that the assay meets the higher standards established by IVDR. It ensures the continued availability of this trusted qualitative assay to clinical geneticists and other healthcare professionals throughout the EU.